🔗 Permalink

Inventor profile of:

Manuela MALLY

City:

Watt

Country:

Switzerland

Published Applications:

Last publication date:

2026-02-26

Top Assignees for applications by Manuela MALLY

The entities that hold a legal rights for patent applications filed by inventor MALLY Manuela:

JANSSEN PHARMACEUTICALS, INC. 6 Titusville, NJ United States
GlaxoSmithKline Biologicals S.A. 3 Rixensart, Belgium
LIMMATECH BIOLOGICS AG 2 Schlieren, Switzerland
GLYCOVAXYN AG 1 Schlieren, Switzerland
GlaxoSmith Kline Biologicals S.A. 1 Rixensart, Belgium
GLAXOSMITHKLINE BIOLOGICAL SA 1 Rixensart, Belgium
GLYCOVAXYN AG 1 Schlieren, Sweden
GlaxosSmithKline Biologicals S.A. 1 , Belgium
GLAXOSMITHKLINE CIOLOGICALS S.A. 1 Rixensart, Belgium
EIDGENÖSSISCHE TECHNISCHE HOCHSCHULE ZÜRICH 1 Zurich, Switzerland

Recent patent applications by MALLY Manuela

Manuela MALLY from Watt, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260055211A1

Chemistry; metallurgy

GLYCOENGINEERED POLYPEPTIDES TARGETING ANTI-NEUTROPHIL AUTOANTIBODIES AND USES THEREOF

#2 | 2026-02-26

US20260055191A1

Chemistry; metallurgy

GLYCOENGINEERED POLYPEPTIDES TARGETING IMMUNOGLOBULIN A AND COMPLEXES COMPRISING THE SAME

#3 | 2025-09-11

US20250282886A1

Chemistry; metallurgy

GLYCAN-MEDIATED PROTEIN DEGRADATION

#4 | 2025-09-11

US20250281626A1

Human necessities

MANNOSE 3 GLYCAN-MEDIATED PROTEIN DEGRADATION

#5 | 2025-07-10

US20250222093A1

Human necessities

METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF

#6 | 2024-09-26

US20240316172A1

Human necessities

BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF

#7 | 2024-08-29

US20240287568A1

Chemistry; metallurgy

Engineered and Fully-Functional Customized Glycoproteins

#8 | 2023-11-16

US20230364214A1

Human necessities

Polysaccharide and uses thereof

#9 | 2023-06-22

US20230190926A1

Human necessities

Methods of producing bioconjugates of O-antigen polysaccharides, compositions thereof, and methods of use thereof

#10 | 2023-04-20

US20230118878A1

Human necessities

Bioconjugates of O-antigen polysaccharides, methods of production thereof, and methods of use thereof

#11 | 2023-03-02

US20230062987A1

Human necessities

Methods and compositions for immune protection against extra-intestinal pathogenic

#12 | 2022-08-04

US20220242919A1

Chemistry; metallurgy

METHODS OF PRODUCING GLYCOSYLATED PROTEINS

#13 | 2021-10-28

US20210332403A1

Chemistry; metallurgy

Engineered and fully-functional customized glycoproteins

#14 | 2021-05-27

US20210154286A1

Human necessities

Polysaccharide and uses thereof

#15 | 2021-02-18

US20210046171A1

Human necessities

Methods and compositions for immune protection against extra-intestinal pathogenic

#16 | 2020-11-12

US20200353073A1

Human necessities

Methods of producing bioconjugates of o-antigen polysaccharides, compositions thereof, and methods of use thereof

#17 | 2020-10-08

US20200316184A1

Human necessities

Bioconjugates of o-antigen polysaccharides, methods of production thereof, and methods of use thereof

#18 | 2020-04-30

US20200129605A1

Human necessities

Polysaccharide and uses thereof

#19 | 2018-12-13

US20180354997A1

Chemistry; metallurgy

Methods of producing glycosylated proteins

#20 | 2018-08-30

US20180243393A1

Human necessities

Methods and compositions for immune protection against extra-intestinal pathogenic

#21 | 2017-11-30

US20170340718A1

Human necessities

Polysaccharide and uses thereof

#22 | 2015-08-27

US20150238588A1

Human necessities

Polysaccharide and uses thereof

InventorID:

2049261 ⎘